• Return to Headlines

20.5% Return Seen to Date on SmarTrend Blueprint Medici Call (BPMC)

By Shiri Gupta

SmarTrend identified an Uptrend for Blueprint Medici (NASDAQ:BPMC) on February 15th, 2018 at $82.39. In approximately 4 weeks, Blueprint Medici has returned 20.53% as of today's recent price of $99.30.

In the past 52 weeks, shares of Blueprint Medici have traded between a low of $17.35 and a high of $102.10 and are now at $99.30, which is 472% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.6% while the 50-day MA has declined 1.1%.

Blueprint Medicines Corporation develops and distributes biomedical treatments. The Company researches and produces medicines and treatments for cancer targeting the molecular differences. Blueprint Medicines focuses selective drugs for genomically defined cancer patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Blueprint Medici shares.

Log in and add Blueprint Medici (BPMC) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights blueprint medici

Ticker(s): BPMC